Form 20-F BioNTech SE For: Dec 31
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20240320/APVZB22CZ22FD2Z2222G22ZLQBCBZZ229E62
Filed on: March 20, 2024
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Reiterates Buy Rating on BioNTech (BNTX) Following Lung Cancer Updates
- A $57 Billion Antiviral Market Is Taking Shape As The World Prepares For The Next Viral Threat
- Foundation Software to Bring Back Its All-User Conference, CONVERGE27
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
